Use access key #2 to skip to page content.
$46.00 -0.04 (-0.09%)
7/3/2008 1:00 PM

Datascope Corp (DSCP)

CAPS Rating:
*

A medical device company that develops, manufactures and markets proprietary products for clinical health care markets in interventional cardiology and radiology, cardiovascular and vascular surgery, anesthesiology, emergency medicine and critical care.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other players to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating DSCP

Add Stock to Watchlist

What the Community Thinks Add a widget featuring this stock to your blog!

Total Players

14 Outperforms
11 Underperforms
 

All-Stars

4 Outperforms
5 Underperforms
 

Wall Street

2 Outperforms
0 Underperforms
 

Players bullish on DSCP are also bullish on:

Players bearish on DSCP are also bearish on:

Ticker Tags

Equipment (65), Major 2005 Lawsuit (8), Medical Appliances & Equipment (106), Medical Device (42), CEO over 70 (8), Micro Cap (4824), Small Cap (1922), Dividend (202)
Suggest a tag

Datascope Corp At A Glance

Current Price: $46.00
Last Trade Time: 7/3/2008 1:00 PM
Open: $0.00
Previous Close: $46.04
Daily Range: $45.98 - $46.32
52-Week Range: $29.29 - $48.75
Volume: 74,932
Market Cap: $720.94M
P/E Ratio: 22.79
Compare Our Special Broker Offers!

Stock Trends

DSCP VS S&P 500 (SPY)

DSCP 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for DSCP

More Headlines...

Top Bull Pitch

Recs

2

Datascope Corp (DSCP)

Avatar trlckyfool (96.75) Submitted: 10/05/06 11:56 PM

"Datascope Corporation, a small-cap value company in the health care sector, is expected to significantly outperform the market over the next six months with less than average risk." -MSN MONEY

Replies: 1 | Reply | Permalink

Top Bear Pitch

Recs

1

Datascope Corp (DSCP)

Avatar hirshey (96.82) Submitted: 12/18/06 3:01 AM

Company has declining and negative earnings and sales growth. Lack of debt recognized is a huge warning sign

Replies: 0 | Reply | Permalink

CAPS Players

picks per page. CHANGE

Results 1 - 5 of 8 :   1 2 Next »

Recs

0

 (DSCP)

Avatar ScreenerStizBear (38.90) Submitted: 6/26/08 2:29 PM : Underperform Start Price: $48.34 DSCP Score: 2.83

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DSCP)

Avatar tixareforkids (87.10) Submitted: 6/04/08 3:21 PM : Outperform Start Price: $46.18 DSCP Score: 8.05

buy on the rumor...

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DSCP)

Avatar qubit16 (98.44) Submitted: 12/03/07 9:55 PM : Underperform Start Price: $35.45 DSCP Score: -43.62

od

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DSCP)

Avatar majakblue (62.86) Submitted: 7/04/07 12:22 PM : Underperform Start Price: $37.68 DSCP Score: -39.19

Can you say "patent infringements?" Suspect that licensing fees as well as legal costs will cut into this year's profitability which isn't exactly stellar. Another pick to test Heisenberg.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (DSCP)

Avatar vcbthornton (37.68) Submitted: 1/31/07 8:04 PM : Underperform Start Price: $35.32 DSCP Score: -42.61

DSCP makes cardiac assist and monitoring products. They are developing a new segment involved in harvesting blood vessels for coronary bypass. P/E. P/S/ P/B are generally favorable. Negative sales growth compared to same quarter last year. Margins are low. From the SEC report, it looks like cardiac assist is the only thing doing well.

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 8 :   1 2 Next »

Wall Street

Results 1 - 2 of 2  

picks per page. CHANGE Expand All Pitches

Top
Pick
Player NamePlayer RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackWhitman < 20 09/30/07 Outperform NS $33.54+37.15%-17.22%+54.37 Toggle the visibility of 60-Second Pitch and replies
TrackSherman < 20 09/30/07 Outperform NS $33.54+37.15%-17.22%+54.37 Toggle the visibility of 60-Second Pitch and replies

Results 1 - 2 of 2  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners